We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.14B
1-Year Est. Return 48.66%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$319M
AUM Growth
+$18.9M
Cap. Flow
+$6.94M
Cap. Flow %
2.17%
Top 10 Hldgs %
37.77%
Holding
106
New
6
Increased
17
Reduced
26
Closed
10

Top Buys

Rank Stock Value
1
KPTI icon
Karyopharm Therapeutics
KPTI
+$6.87M
2
IBM icon
IBM
IBM
+$6.33M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$3.96M
4
SYK icon
Stryker
SYK
+$2.76M
5
CI icon
Cigna
CI
+$2.33M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$3.67M
2
ARMO
ARMO BioSciences, Inc. Common Stock
ARMO
+$1.74M
3
IBB icon
iShares Biotechnology ETF
IBB
+$1.38M
4
KKR icon
KKR & Co
KKR
+$1.27M
5
TRGP icon
Targa Resources
TRGP
+$841K

Sector Composition

Rank Sector Weight
1 Healthcare 31.66%
2 Technology 16.82%
3 Communication Services 16.5%
4 Industrials 8.67%
5 Miscellaneous 6.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
T icon
26
AT&T
T
$178B
$5.3M 1.66%
218,729
-16
-0% -$402
BXMT icon
27
Blackstone Mortgage Trust
BXMT
$2.31B
$5.04M 1.58%
160,288
-200
-0.1% -$6.3K
DHR icon
28
Danaher
DHR
$152B
$4.57M 1.43%
52,187
– –
LMT icon
29
Lockheed Martin
LMT
$130B
$4.5M 1.41%
15,244
-25
-0.2% -$8.06K
CNI icon
30
Canadian National Railway
CNI
$76.2B
$4.39M 1.38%
53,725
-60
-0.1% -$4.77K
JAZZ icon
31
Jazz Pharmaceuticals
JAZZ
$15.9B
$4.17M 1.31%
+24,200
New +$3.96M
EOG icon
32
EOG Resources
EOG
$75.2B
$3.85M 1.21%
30,918
-100
-0.3% -$11.6K
FLEX icon
33
Flex
FLEX
$40.8B
$3.59M 1.12%
337,534
-49,720
-13% -$558K
UBA
34
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$3.57M 1.12%
157,605
-400
-0.3% -$8.38K
HWM icon
35
Howmet Aerospace
HWM
$106B
$3.5M 1.1%
267,998
-1,208
-0.4% -$17.9K
ABBV icon
36
AbbVie
ABBV
$451B
$3.35M 1.05%
36,210
-100
-0.3% -$9.77K
XOM icon
37
ExxonMobil
XOM
$644B
$2.79M 0.88%
33,781
– –
AMAT icon
38
Applied Materials
AMAT
$366B
$2.45M 0.77%
53,046
-117
-0.2% -$6.03K
CVX icon
39
Chevron
CVX
$396B
$2.4M 0.75%
18,946
– –
GOOG icon
40
Alphabet (Google) Class C
GOOG
$4.19T
$2.38M 0.75%
42,680
+2,300
+6% +$124K
DVY icon
41
iShares Select Dividend ETF
DVY
$23.8B
$2.27M 0.71%
23,175
– –
AMZN icon
42
Amazon
AMZN
$2.87T
$1.79M 0.56%
21,100
+3,400
+19% +$270K
FTV icon
43
Fortive
FTV
$18B
$1.78M 0.56%
36,577
– –
ABT icon
44
Abbott
ABT
$195B
$1.6M 0.5%
26,250
– –
WRK
45
DELISTED
WestRock Company
WRK
$1.42M 0.44%
24,888
– –
NFLX icon
46
Netflix
NFLX
$340B
$1.4M 0.44%
35,700
– –
CHTR icon
47
Charter Communications
CHTR
$18.3B
$1.38M 0.43%
4,721
– –
INTU icon
48
Intuit
INTU
$97.9B
$1.26M 0.39%
6,150
– –
OMC icon
49
Omnicom Group
OMC
$24.2B
$1.22M 0.38%
16,000
– –
LBRDK
50
DELISTED
Liberty Broadband Class C
LBRDK
$1.17M 0.37%
15,396
-521
-3% -$39.5K
1
2
3 4

Similar funds

SC
Shellback Capital Boston, Massachusetts $1.14B AUM 49.89% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
RIM
RW Investment Management Eagle, Idaho $1.14B AUM
VCP
Vista Capital Partners Portland, Oregon $1.14B AUM 21.34% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
SIM
Symetra Investment Management Farmington, Connecticut $1.14B AUM 10.76% 1-Year Est. Return

Private Capital Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, Private Capital Advisors held 106 positions worth $319M, up 6.3% from $300M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Private Capital Advisors's Q2 2018 filing shows 6 new, 17 increased, 26 reduced and 10 closed positions. Its largest new stake was Karyopharm Therapeutics: 27,793 shares worth $7.08M. The largest sale was Meta Platforms (Facebook), an estimated $3.67M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 27% a quarter earlier, followed by Technology and Communication Services.

  • Private Capital Advisors's largest Q2 2018 buy was Karyopharm Therapeutics: 27,793 shares worth $7.08M.
  • Private Capital Advisors added most to IBM in Q2 2018, an estimated $6.33M increase.
  • Private Capital Advisors's biggest Q2 2018 reduction was Meta Platforms (Facebook), cutting an estimated $3.67M.
  • Private Capital Advisors fully exited ARMO BioSciences, Inc. Common Stock in Q2 2018, selling an estimated $1.74M.
  • Private Capital Advisors's ten largest holdings make up 38% of its $319M portfolio in Q2 2018.
  • Private Capital Advisors opened 6 new positions and closed 10 in Q2 2018.
  • Private Capital Advisors's portfolio value rose 6.3% quarter-over-quarter to $319M.

Based on Private Capital Advisors's 13F filing for Q2 2018, filed 10 Jul 2018.